Literature DB >> 20629177

Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells.

Chui-Wei Wong1, Pei-Shan Hou, Shun-Fu Tseng, Chung-Liang Chien, Kou-Juey Wu, Hsin-Fu Chen, Hong-Nerng Ho, Satoru Kyo, Shu-Chun Teng.   

Abstract

The zinc finger Krüppel-like transcription factor 4 (KLF4) has been implicated in cancer formation and stem cell regulation. However, the function of KLF4 in tumorigenesis and stem cell regulation are poorly understood due to limited knowledge of its targets in these cells. In this study, we have revealed a surprising link between KLF4 and regulation of telomerase that offers important insight into how KLF4 contributes to cancer formation and stem cell regulation. KLF4 sufficiently activated expression of the human telomerase catalytic subunit, human telomerase reverse transcriptase (hTERT), in telomerase-low alternative lengthening of telomeres (ALT), and fibroblast cells, while downregulation of KLF4 reduced its expression in cancerous and stem cells, which normally exhibits high expression. Furthermore, KLF4-dependent induction of hTERT was mediated by a KLF4 binding site in the proximal promoter region of hTERT. In human embryonic stem cells, expression of hTERT replaced KLF4 function to maintain their self-renewal. Therefore, our findings demonstrate that hTERT is one of the major targets of KLF4 in cancer and stem cells to maintain long-term proliferation potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629177     DOI: 10.1002/stem.477

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  41 in total

1.  Telomere length and iPSC re-programming: survival of the longest.

Authors:  Richard Allsopp
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

2.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

Review 3.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

Review 4.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 5.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

Review 6.  The molecular underpinnings of totipotency.

Authors:  Sophie M Morgani; Joshua M Brickman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-12-05       Impact factor: 6.237

7.  Effect of Kruppel-like factor 4 on Notch pathway in hepatic stellate cells.

Authors:  Yin-Kai Xue; Jun Tan; Dong-Wei Dou; Ding Chen; Lu-Jia Chen; Huan-Ping Ren; Li-Bo Chen; Xin-Gao Xiong; Hai Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

Review 8.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

9.  Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.

Authors:  Jiajie George Lu; Luan Nguyen; Sara Samadzadeh; Maryam Masouminia; Alejandro Mendoza; Owen Sweeney; Brittany Tillman; Nikoo Afifyan; Timothy Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2018-02-06       Impact factor: 3.362

Review 10.  Current status in cancer cell reprogramming and its clinical implications.

Authors:  Kenan Izgi; Halit Canatan; Banu Iskender
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.